July 16, 2014
Gilead Sciences to Release Second Quarter 2014 Financial Results on Wednesday, July 23, 2014
Conference Call and Webcast to Follow
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul. 16, 2014--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second
quarter 2014 financial results will be released on Wednesday, July 23,
at 4:05 p.m. Eastern Time. At 4:30 p.m. Eastern Time, Gilead’s
management will host a conference call to discuss the company’s
financial results for the second quarter 2014 and provide a general
business update. The conference call will be accessible via the internet
from the company’s website.
To access the webcast link, log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
conference call to ensure adequate time for any software download that
may be required to listen to the webcast. Alternatively, please call
1-877-359-9508 (U.S.) or 1-224-357-2393 (international) and dial the
conference ID 65785151 to access the call. Telephone replay will be
available approximately two hours after the call through 11:59 p.m.
Eastern Time, July 25, 2014. To access the phone replay, please call
1-855-859-2056 (U.S.) or 1-404-537-3406 (international) and dial the
conference ID 65785151. The webcast will be archived on www.gilead.com
for one year.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North and South America, Europe and
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936